Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.28
-0.0200-1.54%
Post-market: 1.280.00000.00%17:50 EDT
Volume:735.89K
Turnover:936.58K
Market Cap:77.17M
PE:-1.46
High:1.30
Open:1.30
Low:1.25
Close:1.30
Loading ...
Aug 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 07, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 03, 2024

Major Issues Report

Form 8-K - Current report